Early Aggressive Fluid Resuscitation Not Better for Pancreatitis
FRIDAY, Sept. 16, 2022 (HealthDay News) -- Early aggressive fluid resuscitation results in a higher incidence of fluid overload and does not improve clinical outcomes for patients presenting with acute pancreatitis, according to a study published in the Sept. 15 issue of the New England Journal of Medicine.
Enrique de-Madaria, M.D., Ph.D., from Dr. Balmis General University Hospital in Alicante, Spain, and colleagues randomly assigned 249 patients at 18 centers who presented with acute pancreatitis to receive goal-directed aggressive or moderate resuscitation with lactated Ringer's solution. Patients were assessed at 12, 24, 48, and 72 hours; fluid resuscitation was adjusted based on the patient's clinical status.
The trial was halted due to between-group differences in the safety outcomes, with no significant difference in the incidence of moderately severe or severe pancreatitis between the groups (22.1 and 17.3 percent in the aggressive- and moderate-resuscitation groups, respectively; adjusted relative risk, 1.30; 95 percent confidence interval, 0.78 to 2.18; P = 0.32). The researchers found that fluid overload developed in 20.5 and 6.3 percent of those who received aggressive and moderate resuscitation, respectively (adjusted relative risk, 2.85; 95 percent confidence interval, 1.36 to 5.94; P = 0.004). The median duration of hospitalization was six and five days in the aggressive- and moderate-resuscitation groups, respectively.
"The use of aggressive fluid resuscitation led to a higher risk of volume overload and did not show the hypothesized benefit in disease-specific outcomes," the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Was this page helpful?
Was this page helpful?
Was this page helpful?
Was this page helpful?
Was this page helpful?
Was this page helpful?
Was this page helpful?
Was this page helpful?
Was this page helpful?
Was this page helpful?
Was this page helpful?
Was this page helpful?
Was this page helpful?
Was this page helpful?
Was this page helpful?
Was this page helpful?
Was this page helpful?
Was this page helpful?
Was this page helpful?
Was this page helpful?
Was this page helpful?
Was this page helpful?
Was this page helpful?
Was this page helpful?
Was this page helpful?
Related Posts
La terapia de reemplazo hormonal no aumenta la tasa de recurrencia de las sobrevivientes al cáncer de mama
MIÉRCOLES, 20 de julio de 2022 (HealthDay News) -- La terapia de reemplazo...
Maternal Smoking Linked to Delayed Embryonic Development
FRIDAY, March 4, 2022 (HealthDay News) -- Periconceptional maternal smoking is...
Sexism May Play Role in Who Performs Your Surgery
THURSDAY, Nov. 11, 2021 (HealthDay News) -- Male doctors are much more likely to...
Un tribunal bloquea por ahora la orden de obligatoriedad de las vacunas de Biden para grandes empresas
LUNES, 8 de noviembre de 2021 (HealthDay News) -- Un panel de tres jueces del...